Cook Children's Medical Center Oncology

Fort Worth, Texas 76104

0 studies enrolling now · 1 studies all time

What they study most

Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia

Studies at this site

• Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients. — Completed